Atomoxetine is effective and well tolerated by girls aged 7 to 13 years who have been diagnosed with attention deficit/hyperactivity disorder (ADHD).
“Atomoxetine significantly decreased ADHD signs and symptoms in girls with ADHD and may offer an alternative to stimulants in the treatment of this disorder,” say researchers from Massachusetts General Hospital in Boston, United States.
“The data reported from this subset analysis of two identical placebo-controlled clinical trials address an important void in what is known about the treatment of school-age girls with ADHD.”
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!